SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 828.32 |
| Enterprise Value ($M) | 815.44 |
| Book Value ($M) | 50.44 |
| Book Value / Share | 0.15 |
| Price / Book | 16.42 |
| NCAV ($M) | 1.83 |
| NCAV / Share | 0.00 |
| Price / NCAV | 453.86 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.20 |
| Return on Assets (ROA) | -0.15 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.49 |
| Current Ratio | 1.66 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 228.43 |
| Assets | 277.05 |
| Liabilities | 226.61 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 99.38 |
| Operating Income | 18.07 |
| Net Income | -28.01 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -10.23 |
| Cash from Investing | -8.13 |
| Cash from Financing | 94.01 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Christopher Jeffery | 8.60 | ||
| 13G/A | Barnard Robert James | 3.40 | ||
| 13G | Ca Pipe Spv, Llc | 8.75 | ||
| 13D/A | Kingsley Kyle Eugene | 6.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| VICP – Vicapsys Life Sciences, Inc. | VINC – Vincerx Pharma, Inc. |
| VIRX – Viracta Therapeutics, Inc. | VRPX – Virpax Pharmaceuticals, Inc. |
| WCUI – Wellness Center USA, Inc. |
Financial data and stock pages provided by
Fintel.io